text in 
English (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mail
Cited by SciELO 
Cited by Google 
Similars in
SciELO 
Similars in Google 
Permalink
Remark
| 1) Why was this study conducted? |
| The objective of this manuscript is to propose a new damage control algorithmic approach to refractory neurogenic shock that includes the use of a REBOA in Zone 3. |
| 2) What were the most relevant results of the study? |
| There are still unanswered questions on spinal cord perfusion and functional outcomes with the use of a REBOA in Zone 3 in trauma patients with refractory neurogenic shock. But it is our belief that its judicial use in these case scenarios can be beneficial to the overall outcome of these patients. |
| 3) What do these results contribute? |
| REBOA can be used in the management of patients with refractory neurogenic shock. |
Introduction
Neurogenic shock is a loss of vasomotor tone and sympathetic innervation to the heart and peripheral vessels due to cervical or upper thoracic spinal cord injury. (T6 and above) 1. The resultant impairment of the descending sympathetic pathways causes vasodilatation of visceral and peripheral blood vessels, pooling of blood, and, consequently, hypotension 2. Also, loss of sympathetic innervation to the heart can cause bradycardia and/or the inability to mount a tachycardic response to hypovolemia. The physiologic effects of neurogenic shock are usually reversed with fluid resuscitation initially, followed by the judicious use of vasopressors when needed 2,3. This manuscript aims to propose a new damage control algorithmic approach to refractory neurogenic shock that includes the use of a REBOA in Zone 3. This proposal is the result of the experience earned during the past 30 years in trauma critical care management of the severely injured patient from the Trauma and Emergency Surgery Group (CTE) of Cali, Colombia, which is made up of experts from the University Hospital del Valle “Evaristo García,” the University Hospital Fundación Valle del Lili, the Universidad del Valle and Universidad Icesi, the Asociación Colombiana de Cirugía, the Pan-American Trauma Society and the collaboration of international specialists from the United States of America.
Refractory neurogenic shock
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is commonly used as an adjunct to resuscitation and bridge to definitive control of non-compressible torso hemorrhage in patients with hemorrhagic shock 4,5. It has also been performed for patients with neurogenic shock to support the central aortic pressure necessary for cerebral, coronary, and spinal cord perfusion 6. Gray et al. reported a case of successful REBOA in a patient with neurogenic shock secondary to a comminuted fracture at C5 with cord contusion. This case is the first report of the use of REBOA for neurogenic shock in a trauma patient. The patient presented after a motorcycle accident with altered mental status and hypotension. The patient was initially resuscitated with blood products and vasopressors. Then, the REBOA was used as an adjunct to maintaining cardiac, cerebral and spinal cord perfusion 7. Besides this case report, there is no clear consensus on REBOA as an adjunct for patients with neurogenic shock resulting from a traumatic spine injury. The concomitant physiological effects of the use of a REBOA in these specific case scenarios are still unclear. Although volume replacement and vasopressors are the cornerstones of the management of neurogenic shock, we believe that REBOA can be used as an adjunct in carefully selected cases to prevent prolonged hypotension and the risk of further anoxic spinal cord injury. For these reasons, we propose the following newly developed damage control stepwise approach to refractory traumatic neurogenic shock (Figure 1):
STEP 1: Attention should be directed towards identifying all immediate life-threatening injuries following the ABCDE mnemonic of ATLS 8. General management of spine and spinal cord trauma, which includes restricting spinal motion. This is accomplished simply by laying the patient supine without rotating or bending the spinal column on a firm surface and an appropriately sized and placed rigid cervical collar.
STEP 2: All other types of shock must be ruled out, especially hypovolemic (hemorrhagic) because, in trauma patients, it is the most common form of shock and can be present in addition to neurogenic shock 9.
STEP 3: Both careful clinical examination and thorough tomographic (Computed Tomography of the C/T/L spine) assessment are critical in identifying the level of the injury 10.
STEP 4: Moderate intravenous volume replacement with intravenous fluids and/or blood products.
STEP 5: If the patient responds to initial fluid resuscitation, the patient should be admitted to the ICU and immediately consult the spine specialist. If the patient does not respond to initial fluid resuscitation, then judicious use of vasopressors should be initiated and atropine to counteract hemodynamically significant bradycardia. The use of a REBOA in Zone 3 may be used to aid in the stabilization of these patients, which can limit the amount of vasopressors required.
STEP 6: If the patient’s hemodynamics are refractory to intra-venous volume and vasopressor therapy, then a REBOA inflated in Zone 3 is recommended to aid in the resuscitation of the patient. Complete REBOA balloon inflation should not be used for more than 45 minutes. Then partial balloon inflation can be used to a maximum of 60 minutes 11. The patient should be admitted to the ICU and immediate consult placed to the spine specialist.
Complications/Discussion
Spinal cord injury and subsequent paralysis during cross-clamping or occlusion of the thoracic aorta is a devastating complication with an overall prevalence that remains between 3 to 23 %, according to the current literature. An animal study in which Zone 1 REBOA were placed in primate models found that inflation times of 45-60 minutes resulted in significant clinical and histological spinal cord ischemia in 50 to 83% of cases. All spinal cord necrosis occurred in the lumbar region 12. This is likely representative of the rich collateralization of vascular supply to the upper spinal cord compared to the distal 13. It has been maintained that higher-level aortic occlusion portents higher risk of cord ischemia. Preventive measures of spinal cord ischemia have centered on the utilization of hypothermia and cerebrospinal fluid drainage. Unfortunately, most of these measures of spinal cord protection are not feasible in the acute trauma setting. Clinical evidence of spinal cord injury was completely mitigated in these animal studies by limiting the balloon inflation time in the thoracic aorta to a maximum of 30 minutes 14. Considering all these findings, we suggest that the use of Zone 3 complete aortic occlusion with a REBOA be limited to 30 minutes in refractory cases of traumatic neurogenic shock.
Prior anatomical angiographic assessment has shown that the human body has significant intercostal-to-lumbar and/or internal mammary-to-epigastric arterial collateral blood flow and reasonable opacification of the intra-abdominal organs with a fully occlusive thoracic aortic balloon. These findings suggest the possibility of a robust collateral blood flow of the spinal cord 11. The artery of Adamkiewicz (arteria radicularis magna) in humans may arise anywhere from T8 to L2 but is generally found in the T9-T12 distribution. Given that Zone 1 REBOA balloon inflation is commonly above this level this would make it prohibitive to use in refractory neurogenic shock cases and instead makes Zone 3 balloon inflation ideal because blood flow assurance will occur to the brain, heart and spinal cord via the artery of Adamkiewicz 15. Zone 3 REBOA would be then protective of spinal cord injury while at the same time managing refractory hypotension from neurogenic shock.
The proposed algorithm is based on the limited evidence in the literature. Therefore, it is needed to perform research to understand the effect that REBOA can have on spinal cord perfusion and its role in the refractory neurogenic shock.
